These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5670163)

  • 21. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 22. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy of essential hypercholesteremia?].
    Schettler G
    Dtsch Med Wochenschr; 1968 Sep; 93(37):1779. PubMed ID: 5681549
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of clofibrate in the treatment of hyperlipidemia. (Apropos of 61 cases)].
    Warembourg H; Jaillard J
    Rev Atheroscler (Paris); 1966; 8(1):53-5. PubMed ID: 5961028
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effects of clofibrate (Atromid-S) on serum lipids in man.
    Hunninghake DB; Tucker DR; Azarnoff DL
    Circulation; 1969 May; 39(5):675-83. PubMed ID: 5787318
    [No Abstract]   [Full Text] [Related]  

  • 26. Clofibrate in perspective.
    N Engl J Med; 1968 Oct; 279(16):885-6. PubMed ID: 5677725
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medical treatment of hyperlipemia. Indications and modern preparations].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
    [No Abstract]   [Full Text] [Related]  

  • 28. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug therapy of hyperlipidemia.
    Prihoda JS; Illingworth DR
    Curr Probl Cardiol; 1992 Sep; 17(9):545-605. PubMed ID: 1446461
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperlipidemia.
    Eaton CB
    Prim Care; 2005 Dec; 32(4):1027-55, viii. PubMed ID: 16326226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].
    Baranova LV
    Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932
    [No Abstract]   [Full Text] [Related]  

  • 34. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM
    Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of lipolytic drugs.
    Geill T
    Gerontol Clin (Basel); 1965; 7(6):321-9. PubMed ID: 5871676
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
    Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
    Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J
    Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
    [No Abstract]   [Full Text] [Related]  

  • 40. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
    Frohlich J; Fodor G; McPherson R; Genest J; Langner N
    Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.